Infusion Therapy Market Size, Share and Growth Analysis - Forecast Trends and Outlook (2025-2034)
Description
The global infusion therapy market was valued at USD 50.81 Billion in 2024 and is expected to grow at a CAGR of 6.80% , reaching USD 98.10 Billion by 2034 . The market growth is driven by the rising demand for advanced surgical equipment, coupled with large-scale hospital infrastructure investments and government funding initiatives across the region.
Key Trends and Insights
The market is expanding rapidly due to the growing prevalence of chronic diseases, rising hospital admissions, and advancements in infusion technology. Increasing demand for home-based infusion services, coupled with innovations in infusion pumps and catheters, is reshaping care delivery. Favorable healthcare investments, expanding aging populations, and the shift toward minimally invasive treatments are further propelling market growth. Additionally, digital integration and telehealth capabilities are enhancing patient monitoring, ensuring better outcomes, and boosting overall market adoption. The market is expected to grow at a CAGR of 6.80% during the forecast period of 2025-2034 and attain a market value of USD 98.10 Billion by 2034 .
Infusion Therapy Market Growth Drivers
Technological Advancements Driving Market Growth
In January 2025, ICU Medical introduced its Plum Solo™ and Plum Duo™ precision IV pumps with FDA clearance. These devices offer enhanced dosing accuracy, improved safety features, and seamless integration into hospital systems. This innovation strengthens hospital adoption of advanced infusion devices, increases operational efficiency, and supports better patient outcomes. As healthcare facilities seek reliable and precise infusion solutions, such technological advancements directly drive the global infusion therapy market’s growth and adoption across both developed and emerging regions.
Infusion Therapy Market Trends
Major market trends include technological innovations, new product launches, and increasing adoption in hospitals and home-based care.
Adoption of Precision-focused Critical Care Systems to Boost Market Value
In August 2025, Terumo India launched Terufusion advanced infusion systems to enhance precision and safety in critical care. Hospitals are increasingly adopting these devices to improve clinical accuracy, reduce complications, and support complex patient management. The launch reflects the growing demand for technologically sophisticated infusion equipment capable of seamless integration into hospital workflows. Such innovations are driving market expansion by encouraging broader adoption across emerging and developed regions, increasing the need for advanced infusion solutions in high-acuity healthcare settings worldwide.
Specialized Infusion Devices to Expand Therapeutic Application, Bolstering Global Infusion Therapy Market Demand
In June 2025, Trisalus Life Sciences introduced Trinav FLX infusion, targeting oncology and chronic disease therapies. This specialized system allows hospitals and outpatient centers to safely administer advanced treatments, improving patient outcomes and operational efficiency. Its launch demonstrates the market’s shift toward diversified therapeutic applications, moving beyond traditional hospital use. Growing adoption of such devices by healthcare providers enhances access to complex treatments, drives sales of innovative infusion systems, and supports sustained global market growth by addressing the increasing demand for reliable, precise, and flexible infusion solutions.
Application of Long-lasting Infusion Therapies to Drive Market Demand
In May 2025, Johnson & Johnson reported that a single infusion of Carvykti (ciltacabtagene autoleucel) delivered durable remissions in patients with relapsed or refractory multiple myeloma. This achievement highlights the growing reliance on infusion therapies for chronic and complex conditions. Hospitals and specialty centers are increasingly investing in modern infusion devices capable of handling advanced therapies. As life-saving treatments continue to adopt infusion delivery methods, demand for reliable, high-performance infusion systems is expected to rise, further boosting the global infusion therapy market.
Regulatory Approvals to Accelerate Global Infusion Therapy Market Growth
In March 2025, Supernus received FDA approval for ONAPGOTM (apomorphine) infusion, facilitating broader clinical adoption. Regulatory support ensures faster integration of innovative infusion treatments, enabling healthcare providers to offer advanced therapies safely. Approval also signals strong industry investment in research and development, encouraging manufacturers to expand product portfolios and innovate. Enhanced access to approved infusion solutions improves patient outcomes and strengthens market penetration, ultimately driving sustained growth and adoption of infusion therapy solutions across hospitals, specialty centers, and home-care settings worldwide.
Infusion Therapy Market Share
Hospitals and Clinics to Lead the Market by End User
Hospitals and clinics emerged as the dominant end-use segment in the global infusion therapy market, accounting for the highest revenue share of 43% during the historical period. The preference for hospital-based infusion treatments is driven by the availability of skilled healthcare professionals, advanced infrastructure, and the need for continuous monitoring during therapy. Additionally, the increasing prevalence of chronic diseases and rising hospital admissions worldwide have reinforced demand for infusion services. This trend positions hospitals as the primary growth driver in the market.
Infusion Therapy Market Analysis by Region
North America led the market, capturing a substantial 56% revenue share during the historical period. The region’s dominance is supported by advanced healthcare infrastructure, high adoption of technologically sophisticated infusion devices, and strong investments in chronic disease management. Furthermore, increasing demand for home-based and outpatient infusion services, coupled with a well-established regulatory framework, has enhanced market penetration. The presence of leading market players and growing awareness of patient-centric therapies further consolidate North America’s position as the largest regional market.
Leading Players in the Infusion Therapy Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
B. Braun SE
Founded in 1839, B. Braun SE is headquartered in Melsungen, Germany. It’s a global leader in medical devices and pharmaceuticals. Its broad product portfolio includes infusion therapy (infusion pumps, solutions, IV access), surgery and orthopaedics, anaesthesia care, extracorporeal blood treatment, wound management, and hospital consumables. The company operates through divisions such as Hospital Care, Aesculap (surgical instruments), Avitum (dialysis), and the Outpatient Market, supplying hospitals, clinics, and home care globally.
Medtronic plc
Founded in 1949, Medtronic plc is a medical technology company headquartered in Dublin, Ireland, with operational headquarters in the United States. It develops and commercializes device-based therapies, including cardiovascular and vascular systems (pacemakers, defibrillators, stents), neuroscience (spinal stimulators, brain modulation), medical-surgical devices (surgical tools, robotics), and diabetes care. Medtronic serves hospitals, physicians, and integrated healthcare systems worldwide.
Becton, Dickinson and Company (BD)
Founded in 1897, Becton, Dickinson and Company (BD) is headquartered in Franklin Lakes, New Jersey, USA. BD is a major player in medical technology and devices, offering products across three divisions: BD Medical, BD Life Sciences, and BD Interventional. Its portfolio includes infusion systems (large volume and syringe pumps, infusion sets), drug delivery devices, diagnostics, and safety-engineered medical equipment. BD serves hospitals, outpatient care, and home health markets globally.
ICU Medical
Established in 1984, ICU Medical is headquartered in San Clemente, California, USA. It specializes in infusion therapy and related critical care products. Its offerings include IV smart pumps, ambulatory and large-volume infusion pumps, IV solutions and sets, needle-free connectors, closed system drug handling systems, anesthesia products, patient monitoring, and respiratory and temperature management systems. ICU supplies acute care hospitals, clinics, and alternative care sites.
Other key players in the market include Baxter AG, Terumo Medical Corporation, Fresenius Kabi, Cardinal Health, Mediprim GmbH, and Polymedicure.
Infusion Therapy Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Ambulatory Infusion Pumps
Stationary Infusion Pumps
Syringe Infusion Pumps
Disposable Pumps
Large Volume Pumps
Elastomeric Pumps
Key Trends and Insights
- By therapy type, the pain management segment accounted for the largest revenue share (37%) during the historical period.
- By end use, hospitals and clinics dominated the market with the highest revenue share of 43% in the historical period.
- North America emerged as the leading regional market, capturing a 56% revenue share in the historical period.
- Market Size (2024): USD 50.81 Billion
- Projected Market Size (2034): USD 98.10 Billion
- CAGR (2025-2034): 6.80%
The market is expanding rapidly due to the growing prevalence of chronic diseases, rising hospital admissions, and advancements in infusion technology. Increasing demand for home-based infusion services, coupled with innovations in infusion pumps and catheters, is reshaping care delivery. Favorable healthcare investments, expanding aging populations, and the shift toward minimally invasive treatments are further propelling market growth. Additionally, digital integration and telehealth capabilities are enhancing patient monitoring, ensuring better outcomes, and boosting overall market adoption. The market is expected to grow at a CAGR of 6.80% during the forecast period of 2025-2034 and attain a market value of USD 98.10 Billion by 2034 .
Infusion Therapy Market Growth Drivers
Technological Advancements Driving Market Growth
In January 2025, ICU Medical introduced its Plum Solo™ and Plum Duo™ precision IV pumps with FDA clearance. These devices offer enhanced dosing accuracy, improved safety features, and seamless integration into hospital systems. This innovation strengthens hospital adoption of advanced infusion devices, increases operational efficiency, and supports better patient outcomes. As healthcare facilities seek reliable and precise infusion solutions, such technological advancements directly drive the global infusion therapy market’s growth and adoption across both developed and emerging regions.
Infusion Therapy Market Trends
Major market trends include technological innovations, new product launches, and increasing adoption in hospitals and home-based care.
Adoption of Precision-focused Critical Care Systems to Boost Market Value
In August 2025, Terumo India launched Terufusion advanced infusion systems to enhance precision and safety in critical care. Hospitals are increasingly adopting these devices to improve clinical accuracy, reduce complications, and support complex patient management. The launch reflects the growing demand for technologically sophisticated infusion equipment capable of seamless integration into hospital workflows. Such innovations are driving market expansion by encouraging broader adoption across emerging and developed regions, increasing the need for advanced infusion solutions in high-acuity healthcare settings worldwide.
Specialized Infusion Devices to Expand Therapeutic Application, Bolstering Global Infusion Therapy Market Demand
In June 2025, Trisalus Life Sciences introduced Trinav FLX infusion, targeting oncology and chronic disease therapies. This specialized system allows hospitals and outpatient centers to safely administer advanced treatments, improving patient outcomes and operational efficiency. Its launch demonstrates the market’s shift toward diversified therapeutic applications, moving beyond traditional hospital use. Growing adoption of such devices by healthcare providers enhances access to complex treatments, drives sales of innovative infusion systems, and supports sustained global market growth by addressing the increasing demand for reliable, precise, and flexible infusion solutions.
Application of Long-lasting Infusion Therapies to Drive Market Demand
In May 2025, Johnson & Johnson reported that a single infusion of Carvykti (ciltacabtagene autoleucel) delivered durable remissions in patients with relapsed or refractory multiple myeloma. This achievement highlights the growing reliance on infusion therapies for chronic and complex conditions. Hospitals and specialty centers are increasingly investing in modern infusion devices capable of handling advanced therapies. As life-saving treatments continue to adopt infusion delivery methods, demand for reliable, high-performance infusion systems is expected to rise, further boosting the global infusion therapy market.
Regulatory Approvals to Accelerate Global Infusion Therapy Market Growth
In March 2025, Supernus received FDA approval for ONAPGOTM (apomorphine) infusion, facilitating broader clinical adoption. Regulatory support ensures faster integration of innovative infusion treatments, enabling healthcare providers to offer advanced therapies safely. Approval also signals strong industry investment in research and development, encouraging manufacturers to expand product portfolios and innovate. Enhanced access to approved infusion solutions improves patient outcomes and strengthens market penetration, ultimately driving sustained growth and adoption of infusion therapy solutions across hospitals, specialty centers, and home-care settings worldwide.
Infusion Therapy Market Share
Hospitals and Clinics to Lead the Market by End User
Hospitals and clinics emerged as the dominant end-use segment in the global infusion therapy market, accounting for the highest revenue share of 43% during the historical period. The preference for hospital-based infusion treatments is driven by the availability of skilled healthcare professionals, advanced infrastructure, and the need for continuous monitoring during therapy. Additionally, the increasing prevalence of chronic diseases and rising hospital admissions worldwide have reinforced demand for infusion services. This trend positions hospitals as the primary growth driver in the market.
Infusion Therapy Market Analysis by Region
North America led the market, capturing a substantial 56% revenue share during the historical period. The region’s dominance is supported by advanced healthcare infrastructure, high adoption of technologically sophisticated infusion devices, and strong investments in chronic disease management. Furthermore, increasing demand for home-based and outpatient infusion services, coupled with a well-established regulatory framework, has enhanced market penetration. The presence of leading market players and growing awareness of patient-centric therapies further consolidate North America’s position as the largest regional market.
Leading Players in the Infusion Therapy Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
B. Braun SE
Founded in 1839, B. Braun SE is headquartered in Melsungen, Germany. It’s a global leader in medical devices and pharmaceuticals. Its broad product portfolio includes infusion therapy (infusion pumps, solutions, IV access), surgery and orthopaedics, anaesthesia care, extracorporeal blood treatment, wound management, and hospital consumables. The company operates through divisions such as Hospital Care, Aesculap (surgical instruments), Avitum (dialysis), and the Outpatient Market, supplying hospitals, clinics, and home care globally.
Medtronic plc
Founded in 1949, Medtronic plc is a medical technology company headquartered in Dublin, Ireland, with operational headquarters in the United States. It develops and commercializes device-based therapies, including cardiovascular and vascular systems (pacemakers, defibrillators, stents), neuroscience (spinal stimulators, brain modulation), medical-surgical devices (surgical tools, robotics), and diabetes care. Medtronic serves hospitals, physicians, and integrated healthcare systems worldwide.
Becton, Dickinson and Company (BD)
Founded in 1897, Becton, Dickinson and Company (BD) is headquartered in Franklin Lakes, New Jersey, USA. BD is a major player in medical technology and devices, offering products across three divisions: BD Medical, BD Life Sciences, and BD Interventional. Its portfolio includes infusion systems (large volume and syringe pumps, infusion sets), drug delivery devices, diagnostics, and safety-engineered medical equipment. BD serves hospitals, outpatient care, and home health markets globally.
ICU Medical
Established in 1984, ICU Medical is headquartered in San Clemente, California, USA. It specializes in infusion therapy and related critical care products. Its offerings include IV smart pumps, ambulatory and large-volume infusion pumps, IV solutions and sets, needle-free connectors, closed system drug handling systems, anesthesia products, patient monitoring, and respiratory and temperature management systems. ICU supplies acute care hospitals, clinics, and alternative care sites.
Other key players in the market include Baxter AG, Terumo Medical Corporation, Fresenius Kabi, Cardinal Health, Mediprim GmbH, and Polymedicure.
Infusion Therapy Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Infusion Pumps
- Infusion Sets
- Accessories
- Cancer
- Gastrointestinal Disorders
- Congestive Heart Failure
- Rheumatoid Arthritis
- Hemophilia
- Immune Deficiencies
- Others
- Antibiotic/Antiviral
- Anti-Coagulation
- Anti-Emetics
- Blood Component Stimulating Factor
- Chemotherapy
- Nutrition
- Hydration
- Pain Management
- Others
- Hospitals and Clinics
- Ambulatory Surgical Centers (ASCs)
- Homecare Settings
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- What was the global infusion therapy market value in 2024?
- What is the global infusion therapy market forecast outlook for 2025-2034?
- What is the market breakup based on product?
- What is the market breakup based on the indication?
- What is the market breakup based on therapy type?
- What is the market breakup based on the end user?
- What are the major factors aiding the global infusion therapy market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major global infusion therapy market trends?
- Which product will lead the market segment?
- Which indication will lead the market segment?
- Which therapy type will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the global infusion therapy market?
- What are the current unmet needs and challenges in the market?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Infusion Therapy Market Overview
- 3.1 Global Infusion Therapy Market Historical Value (2018-2024)
- 3.2 Global Infusion Therapy Market Forecast Value (2025-2034)
- 4 Global Infusion Therapy Market Landscape
- 4.1 Global Infusion Therapy Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Infusion Therapy Market: Service Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Indication
- 4.2.3 Analysis by Therapy Type
- 5 Global Infusion Therapy Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 PESTEL Analysis
- 5.3.1 Political
- 5.3.2 Economic
- 5.3.3 Social
- 5.3.4 Technological
- 5.3.5 Legal
- 5.3.6 Environment
- 5.4 Porter’s Five Forces Model
- 5.4.1 Bargaining Power of Suppliers
- 5.4.2 Bargaining Power of Buyers
- 5.4.3 Threat of New Entrants
- 5.4.4 Threat of Substitutes
- 5.4.5 Degree of Rivalry
- 5.5 Key Demand Indicators
- 5.6 Key Price Indicators
- 5.7 Industry Events, Initiatives, and Trends
- 5.8 Value Chain Analysis
- 6 Global Infusion Therapy Market Segmentation (218-2034)
- 6.1 Global Infusion Therapy Market (2018-2034) by Product
- 6.1.1 Infusion Pumps
- 6.1.1.1 Ambulatory Infusion Pumps
- 6.1.1.2 Stationary Infusion Pumps
- 6.1.1.3 Syringe Infusion Pumps
- 6.1.1.4 Disposable Pumps
- 6.1.1.5 Large Volume Pumps
- 6.1.1.6 Elastomeric Pumps
- 6.1.2 Infusion Sets
- 6.1.3 Accessories
- 6.2 Global Infusion Therapy Market (2018-2034) by Indication
- 6.2.1 Cancer
- 6.2.2 Gastrointestinal Disorders
- 6.2.3 Congestive Heart Failure
- 6.2.4 Rheumatoid Arthritis
- 6.2.5 Hemophilia
- 6.2.6 Immune Deficiencies
- 6.2.7 Others
- 6.3 Global Infusion Therapy Market (2018-2034) by Therapy Type
- 6.3.1 Antibiotic/Antiviral
- 6.3.2 Anti-Coagulation
- 6.3.3 Anti-Emetics
- 6.3.4 Blood Component Stimulating Factor
- 6.3.5 Chemotherapy
- 6.3.6 Nutrition
- 6.3.7 Hydration
- 6.3.8 Pain Management
- 6.3.9 Others
- 6.4 Global Infusion Therapy Market (2018-2034) by End User
- 6.4.1 Hospitals and Clinics
- 6.4.2 Ambulatory Surgical Centers (ASCs)
- 6.4.3 Homecare Settings
- 6.4.4 Others
- 6.5 Global Infusion Therapy Market (2018-2034) by Region
- 6.5.1 North America
- 6.5.2 Europe
- 6.5.3 Asia Pacific
- 6.5.4 Latin America
- 6.5.5 Middle East and Africa
- 7 North America Infusion Therapy Market (218-2034)
- 7.1 North America Infusion Therapy Market (2018-2034) by Product
- 7.1.1 Infusion Pumps
- 7.1.1.1 Ambulatory Infusion Pumps
- 7.1.1.2 Stationary Infusion Pumps
- 7.1.1.3 Syringe Infusion Pumps
- 7.1.1.4 Disposable Pumps
- 7.1.1.5 Large Volume Pumps
- 7.1.1.6 Elastomeric Pumps
- 7.1.2 Infusion Sets
- 7.1.3 Accessories
- 7.2 North America Infusion Therapy Market (2018-2034) by Indication
- 7.2.1 Cancer
- 7.2.2 Gastrointestinal Disorders
- 7.2.3 Congestive Heart Failure
- 7.2.4 Rheumatoid Arthritis
- 7.2.5 Hemophilia
- 7.2.6 Immune Deficiencies
- 7.2.7 Others
- 7.3 North America Infusion Therapy Market (2018-2034) by Therapy Type
- 7.3.1 Antibiotic/Antiviral
- 7.3.2 Anti-Coagulation
- 7.3.3 Anti-Emetics
- 7.3.4 Blood Component Stimulating Factor
- 7.3.5 Chemotherapy
- 7.3.6 Nutrition
- 7.3.7 Hydration
- 7.3.8 Pain Management
- 7.3.9 Others
- 7.4 North America Infusion Therapy Market (2018-2034) by End User
- 7.4.1 Hospitals and Clinics
- 7.4.2 Ambulatory Surgical Centers (ASCs)
- 7.4.3 Homecare Settings
- 7.4.4 Others
- 7.5 North America Infusion Therapy Market (2018-2034) by Country
- 7.5.1 United States
- 7.5.1.1 United States Infusion Therapy Market (2018-2034) by Product
- 7.5.2 Canada
- 7.5.2.1 Canada Infusion Therapy Market (2018-2034) by Product
- 8 Europe Infusion Therapy Market (218-2034)
- 8.1 Europe Infusion Therapy Market (2018-2034) by Product
- 8.1.1 Infusion Pumps
- 8.1.1.1 Ambulatory Infusion Pumps
- 8.1.1.2 Stationary Infusion Pumps
- 8.1.1.3 Syringe Infusion Pumps
- 8.1.1.4 Disposable Pumps
- 8.1.1.5 Large Volume Pumps
- 8.1.1.6 Elastomeric Pumps
- 8.1.2 Infusion Sets
- 8.1.3 Accessories
- 8.2 Europe Infusion Therapy Market (2018-2034) by Indication
- 8.2.1 Cancer
- 8.2.2 Gastrointestinal Disorders
- 8.2.3 Congestive Heart Failure
- 8.2.4 Rheumatoid Arthritis
- 8.2.5 Hemophilia
- 8.2.6 Immune Deficiencies
- 8.2.7 Others
- 8.3 Europe Infusion Therapy Market (2018-2034) by Therapy Type
- 8.3.1 Antibiotic/Antiviral
- 8.3.2 Anti-Coagulation
- 8.3.3 Anti-Emetics
- 8.3.4 Blood Component Stimulating Factor
- 8.3.5 Chemotherapy
- 8.3.6 Nutrition
- 8.3.7 Hydration
- 8.3.8 Pain Management
- 8.3.9 Others
- 8.4 Europe Infusion Therapy Market (2018-2034) by End User
- 8.4.1 Hospitals and Clinics
- 8.4.2 Ambulatory Surgical Centers (ASCs)
- 8.4.3 Homecare Settings
- 8.4.4 Others
- 8.5 Europe Infusion Therapy Market (2018-2034) by Country
- 8.5.1 United Kingdom
- 8.5.1.1 United Kingdom Infusion Therapy Market (2018-2034) by Product
- 8.5.2 Germany
- 8.5.2.1 Germany Infusion Therapy Market (2018-2034) by Product
- 8.5.3 France
- 8.5.3.1 France Infusion Therapy Market (2018-2034) by Product
- 8.5.4 Italy
- 8.5.4.1 Italy Infusion Therapy Market (2018-2034) by Product
- 8.5.5 Spain
- 8.5.5.1 Spain Infusion Therapy Market (2018-2034) by Product
- 8.5.6 Others
- 9 Asia Pacific Infusion Therapy Market (218-2034)
- 9.1 Asia Pacific Infusion Therapy Market (2018-2034) by Product
- 9.1.1 Infusion Pumps
- 9.1.1.1 Ambulatory Infusion Pumps
- 9.1.1.2 Stationary Infusion Pumps
- 9.1.1.3 Syringe Infusion Pumps
- 9.1.1.4 Disposable Pumps
- 9.1.1.5 Large Volume Pumps
- 9.1.1.6 Elastomeric Pumps
- 9.1.2 Infusion Sets
- 9.1.3 Accessories
- 9.2 Asia Pacific Infusion Therapy Market (2018-2034) by Indication
- 9.2.1 Cancer
- 9.2.2 Gastrointestinal Disorders
- 9.2.3 Congestive Heart Failure
- 9.2.4 Rheumatoid Arthritis
- 9.2.5 Hemophilia
- 9.2.6 Immune Deficiencies
- 9.2.7 Others
- 9.3 Asia Pacific Infusion Therapy Market (2018-2034) by Therapy Type
- 9.3.1 Antibiotic/Antiviral
- 9.3.2 Anti-Coagulation
- 9.3.3 Anti-Emetics
- 9.3.4 Blood Component Stimulating Factor
- 9.3.5 Chemotherapy
- 9.3.6 Nutrition
- 9.3.7 Hydration
- 9.3.8 Pain Management
- 9.3.9 Others
- 9.4 Asia Pacific Infusion Therapy Market (2018-2034) by End User
- 9.4.1 Hospitals and Clinics
- 9.4.2 Ambulatory Surgical Centers (ASCs)
- 9.4.3 Homecare Settings
- 9.4.4 Others
- 9.5 Asia Pacific Infusion Therapy Market (2018-2034) by Country
- 9.5.1 China
- 9.5.1.1 China Infusion Therapy Market (2018-2034) by Product
- 9.5.2 Japan
- 9.5.2.1 Japan Infusion Therapy Market (2018-2034) by Product
- 9.5.3 India
- 9.5.3.1 India Infusion Therapy Market (2018-2034) by Product
- 9.5.4 ASEAN
- 9.5.4.1 ASEAN Infusion Therapy Market (2018-2034) by Product
- 9.5.5 Australia
- 9.5.5.1 Australia Infusion Therapy Market (2018-2034) by Product
- 9.5.6 Others
- 10 Latin America Infusion Therapy Market (218-2034)
- 10.1 Latin America Infusion Therapy Market (2018-2034) by Product
- 10.1.1 Infusion Pumps
- 10.1.1.1 Ambulatory Infusion Pumps
- 10.1.1.2 Stationary Infusion Pumps
- 10.1.1.3 Syringe Infusion Pumps
- 10.1.1.4 Disposable Pumps
- 10.1.1.5 Large Volume Pumps
- 10.1.1.6 Elastomeric Pumps
- 10.1.2 Infusion Sets
- 10.1.3 Accessories
- 10.2 Latin America Infusion Therapy Market (2018-2034) by Indication
- 10.2.1 Cancer
- 10.2.2 Gastrointestinal Disorders
- 10.2.3 Congestive Heart Failure
- 10.2.4 Rheumatoid Arthritis
- 10.2.5 Hemophilia
- 10.2.6 Immune Deficiencies
- 10.2.7 Others
- 10.3 Latin America Infusion Therapy Market (2018-2034) by Therapy Type
- 10.3.1 Antibiotic/Antiviral
- 10.3.2 Anti-Coagulation
- 10.3.3 Anti-Emetics
- 10.3.4 Blood Component Stimulating Factor
- 10.3.5 Chemotherapy
- 10.3.6 Nutrition
- 10.3.7 Hydration
- 10.3.8 Pain Management
- 10.3.9 Others
- 10.4 Latin America Infusion Therapy Market (2018-2034) by End User
- 10.4.1 Hospitals and Clinics
- 10.4.2 Ambulatory Surgical Centers (ASCs)
- 10.4.3 Homecare Settings
- 10.4.4 Others
- 10.5 Latin America Infusion Therapy Market (2018-2034) by Country
- 10.5.1 Brazil
- 10.5.1.1 Brazil Infusion Therapy Market (2018-2034) by Product
- 10.5.2 Argentina
- 10.5.2.1 Argentina Infusion Therapy Market (2018-2034) by Product
- 10.5.3 Mexico
- 10.5.3.1 Mexico Infusion Therapy Market (2018-2034) by Product
- 10.5.4 Others
- 11 Middle East and Africa Infusion Therapy Market (218-2034)
- 11.1 Middle East and Africa Infusion Therapy Market (2018-2034) by Product
- 11.1.1 Infusion Pumps
- 11.1.1.1 Ambulatory Infusion Pumps
- 11.1.1.2 Stationary Infusion Pumps
- 11.1.1.3 Syringe Infusion Pumps
- 11.1.1.4 Disposable Pumps
- 11.1.1.5 Large Volume Pumps
- 11.1.1.6 Elastomeric Pumps
- 11.1.2 Infusion Sets
- 11.1.3 Accessories
- 11.2 Middle East and Africa Infusion Therapy Market (2018-2034) by Indication
- 11.2.1 Cancer
- 11.2.2 Gastrointestinal Disorders
- 11.2.3 Congestive Heart Failure
- 11.2.4 Rheumatoid Arthritis
- 11.2.5 Hemophilia
- 11.2.6 Immune Deficiencies
- 11.2.7 Others
- 11.3 Middle East and Africa Infusion Therapy Market (2018-2034) by Therapy Type
- 11.3.1 Antibiotic/Antiviral
- 11.3.2 Anti-Coagulation
- 11.3.3 Anti-Emetics
- 11.3.4 Blood Component Stimulating Factor
- 11.3.5 Chemotherapy
- 11.3.6 Nutrition
- 11.3.7 Hydration
- 11.3.8 Pain Management
- 11.3.9 Others
- 11.4 Middle East and Africa Infusion Therapy Market (2018-2034) by End User
- 11.4.1 Hospitals and Clinics
- 11.4.2 Ambulatory Surgical Centers (ASCs)
- 11.4.3 Homecare Settings
- 11.4.4 Others
- 11.5 Middle East and Africa Infusion Therapy Market (2018-2034) by Country
- 11.5.1 Saudi Arabia
- 11.5.1.1 Saudi Arabia Infusion Therapy Market (2018-2034) by Product
- 11.5.2 United Arab Emirates
- 11.5.2.1 United Arab Emirates Infusion Therapy Market (2018-2034) by Product
- 11.5.3 Nigeria
- 11.5.3.1 Nigeria Infusion Therapy Market (2018-2034) by Product
- 11.5.4 South Africa
- 11.5.4.1 South Africa Infusion Therapy Market (2018-2034) by Product
- 11.5.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.2 US FDA
- 12.3 EU EMA
- 12.4 INDIA CDSCO
- 12.5 JAPAN PMDA
- 12.6 Others
- 13 Patent Analysis
- 13.1 Analysis by Technology
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Codes
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Strategic Initiatives
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Initiatives
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Vendor Positioning Analysis
- 16.1.1 Key Vendors
- 16.1.2 Prospective Leaders
- 16.1.3 Niche Leaders
- 16.1.4 Disruptors
- 16.2 Market Share Analysis (Top 5 Companies)
- 16.3 B. Braun SE
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Company News and Developments
- 16.3.5 Certifications
- 16.4 Medtronic plc
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Company News and Developments
- 16.4.5 Certifications
- 16.5 Becton, Dickinson and Company
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Company News and Developments
- 16.5.5 Certifications
- 16.6 ICU Medical
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Company News and Developments
- 16.6.5 Certifications
- 16.7 Baxter AG
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Company News and Developments
- 16.7.5 Certifications
- 16.8 Terumo Medical Corporation
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Company News and Developments
- 16.8.5 Certifications
- 16.9 Fresenius Kabi
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Company News and Developments
- 16.9.5 Certifications
- 16.10 Cardinal Health
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Company News and Developments
- 16.10.5 Certifications
- 16.11 Mediprim GmbH
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Company News and Developments
- 16.11.5 Certifications
- 16.12 Polymedicure
- 16.12.1 Financial Analysis
- 16.12.2 Product Portfolio
- 16.12.3 Demographic Reach and Achievements
- 16.12.4 Company News and Developments
- 16.12.5 Certifications
- 17 Global Infusion Therapy Market – Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
